Biocon Pharma Limited — Atorvastatin Exporter Profile
Indian Pharmaceutical Exporter · #12 for Atorvastatin · $11.4M export value · DGFT Verified
Biocon Pharma Limited is the #12 Indian exporter of Atorvastatin with $11.4M in export value and 229 verified shipments. Biocon Pharma Limited holds a 1.1% market share in Atorvastatin exports across 2 countries. The company exports 8 pharmaceutical products worth $112.4M across 4 therapeutic categories.
Biocon Pharma Limited — Atorvastatin Export Profile: Buyers & Destinations
Where Does Biocon Pharma Limited Export Atorvastatin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $9.5M | 243 | 100.0% |
| PUERTO RICO | $0 | 2 | 0.0% |
Biocon Pharma Limited exports Atorvastatin to 2 countries. The largest destination is UNITED STATES accounting for 100.0% of Biocon Pharma Limited's Atorvastatin shipments. These destinations reflect Biocon Pharma Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Atorvastatin from Biocon Pharma Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| BIOCON PHARMA INC | UNITED STATES | $9.5M | 243 |
| NEOLPHARMA INC | PUERTO RICO | $0 | 2 |
Biocon Pharma Limited supplies Atorvastatin to 2 buyers globally. The largest buyer is BIOCON PHARMA INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Atorvastatin Export Value and How Much Does Biocon Pharma Limited Contribute?
India exported $313.7M worth of Atorvastatin through 15,000 shipments from 477 suppliers to 145 countries, serving 1,291 buyers globally. Biocon Pharma Limited contributes $11.4M to this total, accounting for 1.1% of India's Atorvastatin exports. Biocon Pharma Limited ships Atorvastatin to 2 countries through 2 buyers.
What Is the Average Shipment Value for Biocon Pharma Limited's Atorvastatin Exports?
Biocon Pharma Limited's average Atorvastatin shipment value is $50.0K per consignment, based on 229 shipments totaling $11.4M. The largest destination is UNITED STATES (100.0% of Biocon Pharma Limited's Atorvastatin exports).
How Does Biocon Pharma Limited Compare to Other Indian Atorvastatin Exporters?
Biocon Pharma Limited ranks #12 among 477 Indian Atorvastatin exporters with a 1.1% market share. The top 3 exporters are MSN LABORATORIES PRIVATE LIMITED ($83.7M), AUROBINDO PHARMA LTD ($33.2M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($32.8M). Biocon Pharma Limited processed 229 shipments to 2 destination countries.
What Atorvastatin Formulations Does Biocon Pharma Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ATORVASTATIN CALCIUM TABLETS USP 20 MG (1000S BOTTLES) AVB24030 AVB24031 AVB24032 AVB24033 AVB24034 | $150.0K | 3 |
| Atorvastatin Calcium Tablets USP 10 mg 1000s Bottles - AVA23001 | $100.0K | 2 |
| ATORVASTATIN CALCIUM TABLETS USP 40 MG 1000S BOTTLES BATCH NO:ATC23019 | $91.5K | 2 |
| ATORVASTATIN CALCIUM TABLETS USP 40 MG 1000S BOTTLES BATCH NO:ATC23018 | $91.1K | 2 |
| ATORVASTATIN CALCIUM TABLETS USP 40 MG 1000S BOTTLES BATCH NO:ATC23017 | $91.0K | 2 |
| Atorvastatin Calcium Tablets USP 80 mg | $90.8K | 2 |
| ATORVASTATIN CALCIUM TABLETS USP 10 MG (1000S BOTTLES)AVA23008NOS | $63.4K | 2 |
| ATORVASTATIN CALCIUM TABLETS USP 10 MG 1000S BOTTLESBATCH NO:ATA23005 | $58.5K | 2 |
| ATORVASTATIN CALCIUM TABLETS USP 20 MG (90S BOTTLES) AVB23013NOS | $56.7K | 3 |
| ATORVASTATIN CALCIUM TABLETS USP 20 MG(90S BOTTLES)BATCH NO.AVB24015NOS | $56.3K | 4 |
Biocon Pharma Limited exports 207 distinct Atorvastatin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ATORVASTATIN CALCIUM TABLETS USP 20 MG (1000S BOTTLES) AVB24 with 3 shipments worth $150.0K.
Regulatory Requirements: Exporting Atorvastatin to Key Markets
What Biocon Pharma Limited must comply with to export Atorvastatin to its top destination countries
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Biocon Pharma Limited Compare to Nearest Atorvastatin Exporters?
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | MICRO LABS LIMITED | $13.7M | 413 | 22 | $33.2K |
| 6 | UMEDICA LABORATORIES PRIVATE LIMITED | $11.8M | 235 | 8 | $50.0K |
| 12 | BIOCON PHARMA LIMITED ★ | $11.4M | 229 | 2 | $50.0K |
| 15 | ANNORA PHARMA PRIVATE LIMITED | $8.4M | 426 | 1 | $19.7K |
| 14 | APOTEX RESEARCH PRIVATE LIMITED | $6.2M | 124 | 1 | $50.0K |
Biocon Pharma Limited ranks #12 among 477 Indian Atorvastatin exporters. Average shipment value of $50.0K compared to the market average of $657.7K. The closest competitors by value are MICRO LABS LIMITED and UMEDICA LABORATORIES PRIVATE LIMITED.
Which Indian Ports Ship Atorvastatin Exports?
| Port | Shipments | % Share |
|---|---|---|
| HYDERABAD ICD | 2,042 | 13.6% |
| HYDERABAD ICD (INSNF6) | 1,131 | 7.5% |
| NHAVA SHEVA SEA (INNSA1) | 842 | 5.6% |
| SAHAR AIR | 839 | 5.6% |
| JNPT/ NHAVA SHEVA SEA | 779 | 5.2% |
| DELHI AIR | 613 | 4.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 581 | 3.9% |
| HYDERABAD AIR | 554 | 3.7% |
What Other Cardiovascular Products Does Biocon Pharma Limited Export?
Biocon Pharma Limited also exports these cardiovascular products. Each links to the detailed product page.
About Biocon Pharma Limited
Biocon Pharma Limited exports 8 products worth $112.4M. Beyond Atorvastatin, top products include Calcium, Rosuvastatin, Esomeprazole, Magnesium, Omeprazole. View the complete Biocon Pharma Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Atorvastatin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Atorvastatin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Biocon Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 245 individual customs records matching Biocon Pharma Limited exporting Atorvastatin, covering 207 formulations to 2 countries via 2 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 145+ countries, 1,291+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Atorvastatin Export Data from Biocon Pharma Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Biocon Pharma Limited's Atorvastatin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Biocon Pharma Limited
Full Company Profile →
8 products · $112.4M total trade · 4 categories
Atorvastatin Stats
Company Overview
Top Products by Biocon Pharma Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Biocon Pharma Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Atorvastatin. For current shipment-level data, contact TransData Nexus.